PharmaCyte Biotech News - PMCB

Company Name	Stock Ticker Symbol	Market	Type
PharmaCyte Biotech Inc	PMCB	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.03	-1.40%	2.12	18:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
2.12	2.12	2.31	2.12	2.15

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	8:00	IHNW	FeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring
2/14/2024	15:38	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/06/2024	09:56	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
12/15/2023	17:25	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/28/2023	17:06	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/24/2023	16:00	EDGAR2	Form 8-K - Current report
11/22/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	17:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	17:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/22/2023	16:00	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
11/15/2023	08:30	BW	PharmaCyte Biotech Acquires $5 Million Stake in Emerging..
11/09/2023	17:25	EDGAR2	Form 8-K - Current report
10/31/2023	09:15	BW	PharmaCyte Biotech Provides Corporate Update on..
9/21/2023	17:04	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
9/18/2023	06:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
9/15/2023	17:00	EDGAR2	Form NT 10-Q - Notification of inability to timely file Form..
9/11/2023	21:56	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
9/07/2023	16:05	EDGAR2	Form 8-K - Current report
8/04/2023	16:40	EDGAR2	Form S-3/A - Registration statement under Securities Act of..
8/04/2023	16:01	EDGAR2	Form 8-K - Current report
7/31/2023	17:18	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
7/31/2023	16:42	EDGAR2	Form DEF 14A - Other definitive proxy statements
7/19/2023	10:28	EDGAR2	Form PRE 14A - Other preliminary proxy statements
6/15/2023	09:15	BW	PharmaCyte Biotech Announces Final Results of Tender Offer
5/11/2023	08:30	BW	PharmaCyte Biotech Announces Cash Tender Offer for up to..